①a-zenith home furnishings: The controlling shareholder is planning to transfer the company's stock agreement, and the stocks will be suspended from today. ② sichuan kelun pharmaceutical: Subsidiaries SKB571 and SKB535 have received approval for new drug clinical trial applications from the National Medical Products Administration.
早间公告
Morning announcement
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.